Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

328
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
328
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

145
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
145
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

237
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
237
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Unexpected Encounter: When a Novel Device Algorithm Meets a Novel Ablation System.

Journal of cardiovascular electrophysiology·2026
Same author

Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.

JACC. Cardiovascular interventions·2026
Same author

First-in-Human Clinical Experience With Focal Pulsed Field and Radiofrequency Dual-Modality Ablation for Treatment Refractory Left Ventricular Summit PVCs.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Transcatheter Valve-in-Valve and Iatrogenic ASD Closure for Tricuspid Thrombosis in Heparin-Induced Thrombocytopenia.

JACC. Case reports·2026
Same author

The effect of inter-pulse delay on lesion size: a step towards demystifying pulsed field ablation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

Heat and gas during pulsed field ablation: silent menace or innocent bystander?

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025

Related Experiment Video

Updated: Jun 30, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Sex Disparities in Cardiovascular Disease.

Madeline K Mahowald1, Khadeeja Esmail1, Fatima M Ezzeddine2

  • 1University of Florida College of Medicine, Jacksonville, Florida, US.

Methodist Debakey Cardiovascular Journal
|March 18, 2024
PubMed
Summary

Cardiovascular disease (CVD) is the top cause of death for women, often underdiagnosed and undertreated. This review highlights disparities in CVD risk factors, management, and outcomes, proposing strategies for improvement.

Keywords:
cardiovascular risk factorshealthcare disparitiesischemic heart diseaserepresentation in cardiovascular researchtreatment gapswomen’s cardiovascular health

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

1.2K

Related Experiment Videos

Last Updated: Jun 30, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

1.2K

Area of Science:

  • Cardiology
  • Women's Health
  • Health Disparities

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in women globally.
  • Significant underdiagnosis, undertreatment, and worse outcomes for CVD are observed in women compared to men.
  • Disparities permeate all levels of cardiovascular science and practice, affecting women disproportionately.

Purpose of the Study:

  • To review and highlight the differences in cardiovascular risk factors and management disparities in women.
  • To examine disparities in outcomes for key cardiovascular conditions including ischemic heart disease, heart failure, aortic stenosis, and atrial fibrillation.
  • To assess female representation in clinical trials, leadership roles, and academic institutions within cardiovascular medicine.

Main Methods:

  • Literature review and synthesis of existing research on sex differences in cardiovascular disease.
  • Analysis of data concerning disparities in diagnosis, treatment, and patient outcomes.
  • Examination of female participation and leadership in cardiovascular research and professional societies.

Main Results:

  • Women exhibit distinct cardiovascular risk factor profiles and experience disparities in the management of major cardiovascular diseases.
  • Outcomes for ischemic heart disease, heart failure, aortic stenosis, and atrial fibrillation are often worse in women due to these disparities.
  • Underrepresentation of women in clinical trials and leadership positions exacerbates these inequities.

Conclusions:

  • Addressing sex-based disparities in cardiovascular disease is critical for improving women's health outcomes.
  • Implementing targeted strategies and increasing female representation are essential to overcome existing inequities in cardiovascular care and research.
  • Successful programs demonstrate the feasibility of mitigating these disparities through focused interventions and policy changes.